Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial) - Cornely, Oliver A.; Maertens, Johan; Bresnik, Mark; Ebrahimi, Ramin; Ullmann, Andrew J.; Bouza, Emilio; Heussel, Claus Peter; Lortholary, Olivier; Rieger, Christina; Boehme, Angelika; Aoun, Mickael; Horst, Heinz-August; et al. (Clinical infectious diseases, 2007)
Keywords: Adolescent; Adult; Aged; Amphotericin B - administration & dosage; Amphotericin B - adverse effects; Antifungal Agents - administration & dosage; Antifungal Agents - adverse effects; Antifungals; Articles and Commentaries; Aspergillosis; Aspergillosis - drug therapy; Child; Child, Preschool; Clinical outcomes; Clinical trials; Dosage; Dose-Response Relationship, Drug; Double-Blind Method; Drug therapy; Experimentation; Female; Fungal infections; Human subjects; Humans; Infections; Lung Diseases, Fungal - drug therapy; Lung Diseases, Fungal - immunology; Male; Middle Aged; Mold; Neutropenia; Patients; Prospective Studies; Review boards; Stem cell transplantation; Survival; Survival rates